D. S. Ugdyzhekova

Activation of Type II Cannabinoid Receptors Improves Myocardial Tolerance to Arrhythmogenic Effects of Coronary Occlusion and Reperfusion

D. S. Ugdyzhekova, N. A. Bernatskaya, R. Mekhoulam et al. · Bulletin of Experimental Biology and Medicine · 2001 · 51 citations

Medicine, Cardiology, Pharmacology +16

Endogenous Cannabinoid Anandamide Increases Heart Resistance to Arrhythmogenic Effects of Epinephrine: Role of CB1 and CB2 Receptors

D. S. Ugdyzhekova, N. A. Bernatskaya, J. B. Stefano et al. · Bulletin of Experimental Biology and Medicine · 2001 · 29 citations

Medicine, Cardiology, Pharmacology +12

[Anandamide and R-(+)-methanandamide prevent development of ischemic and reperfusion arrhythmia in rats by stimulation of CB2-receptors].

Roman V. Uzhachenko, D. S. Ugdyzhekova, N A Bernatskaia et al. · PubMed · 2002 · 17 citations

Medicine, Cardiology, Pharmacology +14

Activation of Cannabinoid Receptors Decreases the Area of Ischemic Myocardial Necrosis

D. S. Ugdyzhekova, N. A. Bernatskaya, Raphael Mechoulam et al. · Bulletin of Experimental Biology and Medicine · 2002 · 17 citations

Medicine, Cardiology, Pharmacology +11

Participation Of Central and Peripheral κ₁ and κ₂ Opioid Receptors In Arrhythmogenesis

D. S. Ugdyzhekova · Clinical and Experimental Pharmacology and Physiology · 1999 · 15 citations

Medicine, Cardiology, Pharmacology +17